Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ir O P Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101537373B discloses novel binaphthyl spirocyclic phosphonium salts achieving 98% ee. Ideal for reliable pharmaceutical intermediate supplier seeking cost-effective asymmetric synthesis.
Patent CN116947580A enables high-yield axially chiral compound production. Offers supply chain reliability and cost reduction in fine chemical manufacturing for global partners.
Patent CN103214520B reveals ionic liquid supported chiral ligands enabling efficient catalyst recovery and high enantioselectivity for pharmaceutical intermediates manufacturing.
Patent CN105330608A reveals high-ee urazole synthesis. Enables cost reduction in chiral catalyst manufacturing and reliable supply chain for pharma intermediates.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Novel binaphthyl-based phase transfer catalyst offering high enantioselectivity up to 98% ee. Ideal for pharmaceutical intermediates manufacturing with scalable processes.
Patent CN103087105B details high-efficiency asymmetric hydrogenation for chiral beta-aryl amides, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Novel organocatalyst for asymmetric hydroamination. Reduces transition metal dependency. High enantioselectivity for chiral piperidine synthesis.
Patent CN111285768B introduces a recyclable polyionic liquid copper catalyst for efficient asymmetric Henry reactions in water, offering significant cost reduction in chiral catalyst manufacturing.
Novel iron-catalyzed asymmetric hydrogenation using chiral quinoline imidazoline ligands offers high enantioselectivity and cost-effective alternatives to noble metals for pharmaceutical intermediates.
Patent CN111285769B details a polyionic liquid copper catalyst for efficient, green aqueous Henry reactions, offering high enantioselectivity and simplified supply chains for pharmaceutical intermediates.
Patent CN111484533B discloses novel Ir-SpiroPNP catalysts achieving 99.8% ee in dialkyl ketone hydrogenation, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel heterogeneous copper catalyst enables high yield chiral synthesis for pharmaceutical intermediates supply chain optimization and significant cost reduction capabilities for global buyers.
Patent CN117720467A reveals a novel 4-step route for chiral catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole intermediates with superior purity and scalability.
Patent CN111848322B details a mild resolution method for axially chiral oxindole styrenes using chiral phosphoric acid, offering high enantioselectivity for pharma applications.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.